Dr. Batool Fuad Kirmani MD

"It's a weird thing to talk about, because I think so much of the time when people around you are sick, the overwhelming emotion is, like, you feel bad for them and you want to be there for them and love them, but when someone around you is sick, it often puts a tremendous burden on the people in...

The US Food and Drug Administration (FDA) recently passed a new drug called amantadine extended release capsules to treat dyskinesia in those who have Parkinson’s disease and  are also on medication therapy. The Michael J. Fox Foundation recently created the UNDRS or Unified Dyskinesia Rating...

Multiple sclerosis is an autoimmune disease in which the protective myelin sheath of the nerves is damaged, affecting the transmission of messages to and from the brain and spinal cord. This is a progressive, debilitating disease that results in nerve deterioration which is, unfortunately, an...

In the United States alone, over 400,000 individuals are dealing with the challenges associated with multiple sclerosis (MS). Most recently, Sanofi, an international leader in healthcare, announced FDA approval of the prescription drug Lemtrada, for the treatment of patients with relapsing forms of...

The number of multiple sclerosis patients may not be known, since it is a condition that is not easily diagnosed due to symptoms being unapparent, and because there is no strict requirement for physicians to report cases within their practice. However, it is believed that 2.3 million and more...

A study which was recently published in the Natural Communications journal, outlines a major breakthrough in research around facioscapulohumeral muscular dystrophy, also known as FSHD.The study was performed by the University of Minnesota Medical School. Researchers at the university inserted the...